Genenta Science S.p.A. (GNTA) Financials
GNTA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 36.5 million | 11.5 million |
| Dec. 31, 2025 | 37.4 million | 11.8 million |
| Sept. 30, 2025 | 25.3 million | 11.1 million |
| June 30, 2025 | 25.4 million | 11.1 million |
GNTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -1.9 million | ? |
| Dec. 31, 2025 | -2.0 million | ? |
| Sept. 30, 2025 | -7.1 million | 497 |
| June 30, 2025 | -7.1 million | 500 |
GNTA Net Income
No data available :(
GNTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 32.3 million | - | - |
| Dec. 31, 2025 | 33.0 million | 8.9 million | - |
| Sept. 30, 2025 | 20.7 million | - | - |
| June 30, 2025 | 20.8 million | 8.9 million | - |
GNTA Shares Outstanding
GNTA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 546 | 1.4 million | - | - |
| Dec. 31, 2025 | 559 | 1.5 million | 2.3 million | - |
| Sept. 30, 2025 | 9777 | 1.6 million | 2.3 million | - |
| June 30, 2025 | 9820 | 1.6 million | 2.1 million | - |
GNTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 16083 |
| Dec. 31, 2025 | - | 16476 |
| Sept. 30, 2025 | - | 15251 |
| June 30, 2025 | - | 15317 |
GNTA
Price: $0.83
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Italy
Volume: 5118
Market Capitalization: 46.3 million